086820 — Bio Solution Co Income Statement

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeSmall CapSucker Stock

Annual income statement for Bio Solution Co, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.

	2021 December 31st	2022 December 31st	R2023 December 31st	2024 December 31st	2025 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	11,802	10,102	12,462	12,889	15,200
Cost of Revenue
Gross Profit	7,608	5,927	8,062	8,161	9,590
Selling / General / Administrative Expenses
Research And Development
Depreciation and Amortization
Unusual Expense / Income
Total Operating Expenses	13,374	15,390	17,603	22,967	14,666
Operating Profit	-1,572	-5,289	-5,141	-10,078	534
Gain / Loss on Sale of Assets
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes	-1,685	-8,087	-1,356	-11,928	273
Net Income After Taxes	-1,685	-8,087	-1,356	-11,928	273
Net Income Before Extraordinary Items
Net Income	-1,685	-8,087	-1,356	-11,928	273
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income	-1,685	-8,087	-1,356	-11,928	273
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	-70.6	-336	-56.4	-290	-191
Dividends per Share